SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Core Laboratories N.V. (CLB) trades at a trailing P/E of 24.7, forward P/E of 21.6. Trailing earnings yield is 4.04%, forward earnings yield 4.64%. PEG 8.24. Graham Number is $9.62.
Criteria proven by this page:
- VALUE (65/100, Pass) — P/E is below market average (24.7); analyst target implies upside (+53.7%); earnings yield beats bond yields (4.04%).
- Forward P/E 21.6 (down from trailing 24.7) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 8.24 — above 2.0 suggests expensive relative to earnings growth.
- Trailing Earnings Yield 4.04% — roughly competitive with bond yields (~4.3%), moderate risk-reward. Forward yield improves to 4.64% as earnings recover.
- Analyst consensus target $25.00 (+53.7% upside) — significant upside potential according to Wall Street analysts.
Overall SharesGrow Score: 62/100 with 3/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
65/100
Price-to-Earnings & upside
Proven by this page
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — CLB
Valuation Multiples
P/E (TTM)24.7
Forward P/E21.6
PEG Ratio8.24
Forward PEG1.98
P/B Ratio2.81
P/S Ratio1.48
EV/EBITDA13.1
Per Share Data
EPS (TTM)$0.68
Forward EPS (Est.)$0.75
Book Value / Share$6.02
Revenue / Share$11.32
FCF / Share$0.49
Yields & Fair Value
Earnings Yield4.04%
Forward Earnings Yield4.64%
Dividend Yield0.24%
Graham Number$9.62
SharesGrow IV$57.34 (+252.4%)
Analyst Target$25.00 (+53.7%)
Historical Valuation
| Year |
P/E (TTM) |
PEG Ratio |
P/B Ratio |
P/S Ratio |
Dividend Yield |
| 2016 |
81.7 |
-1.76 |
33.61 |
8.78 |
1.82% |
| 2017 |
58.2 |
1.96 |
32.52 |
7.33 |
2.01% |
| 2018 |
33.2 |
-7.79 |
16.39 |
3.76 |
3.69% |
| 2019 |
16.4 |
0.95 |
9.39 |
2.50 |
5.84% |
| 2020 |
-12.1 |
0.06 |
16.49 |
2.42 |
1.06% |
| 2021 |
52.0 |
-0.43 |
6.56 |
2.18 |
0.18% |
| 2022 |
48.3 |
-20.76 |
5.10 |
1.92 |
0.20% |
| 2023 |
22.5 |
0.26 |
3.67 |
1.62 |
0.23% |
| 2024 |
25.9 |
-1.70 |
3.22 |
1.55 |
0.23% |
| 2025 |
23.4 |
15.70 |
2.66 |
1.42 |
0.25% |
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$1.45 |
$594.74M |
$63.9M |
10.7% |
| 2017 |
$1.88 |
$659.81M |
$83.13M |
12.6% |
| 2018 |
$1.79 |
$700.85M |
$79.53M |
11.3% |
| 2019 |
$2.10 |
$668.21M |
$101.98M |
15.3% |
| 2020 |
$-2.16 |
$487.27M |
$-97.07M |
-19.9% |
| 2021 |
$0.50 |
$470.25M |
$19.73M |
4.2% |
| 2022 |
$0.42 |
$489.74M |
$19.45M |
4% |
| 2023 |
$0.77 |
$509.79M |
$36.68M |
7.2% |
| 2024 |
$0.66 |
$523.85M |
$31.4M |
6% |
| 2025 |
$0.68 |
$526.52M |
$31.8M |
6% |
Analyst Estimates
| Year |
EPS (Avg) |
EPS Range |
Revenue (Avg) |
Revenue Range |
Analysts |
| 2026 |
$0.73 |
$0.71 – $0.74 |
$516.88M |
$516.16M – $517.61M |
1 |
| 2027 |
$0.82 |
$0.82 – $0.82 |
$523.88M |
$523.15M – $524.61M |
1 |
| 2028 |
$1.48 |
$1.48 – $1.48 |
$623M |
$622.13M – $623.87M |
1 |
